Real-world comparative effectiveness of stroke prevention in patients with atrial fibrillation treated with rivaroxaban vs. vitamin k antagonists (RELOAD)

Study protocol

Initial protocol

18735_PRC_OS_Secondary Data_SPAF_v2_final_with signatures_2016-10-27

English (3 MB - PDF) View document

Study results

18735_EUPAS_Abstract

English (67.96 KB - PDF) View document

Study report

18735_Reload_Report 2.0final_06102017_redacted

English (2.86 MB - PDF) View document

Other information

Secondary tabs